Publications
Print PDF
White House Plan to Limit Generic Drug Exclusivity Could Backfire
February 14, 2018
Bronwyn Mixter
Bloomberg BNA Health Care Blog

Axinn partner Chad Landmon was quoted in the Bloomberg BNA Health Care Blog article, "White House Plan to Limit Generic Drug Exclusivity Could Backfire."

Click here to access the article.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.